Literature DB >> 21229622

Anticancer and chemopreventing natural products: some biochemical and therapeutic aspects.

George A Karikas1.   

Abstract

Natural products have afforded a rich source of compounds that have found many applications in cancer chemotherapy. Furthermore, the vast structural spectrum of natural compounds can provide "lead compounds" for therapeutic improvement by molecular modification. Over 70% of anticancer compounds are either natural products, or natural product-derived substances. On the other hand conjugation of toxic natural products to monoclonal antibodies or polymeric carriers can lead to more efficacious targeted therapies. Since less than 15% of higher plants have been systematically investigated, the natural products research towards chemotherapy requires further attention and multi-scientific collaboration. An enforcing application to chemotherapy, using natural products, is also chemoprevention. Apart from vegetables and fruit, more than 1,000 different phytochemicals are already proved to possess interesting chemopreventing activities. Effectiveness of chemopreventing agents reflects their ability to counteract certain upstream signals that leads to genotoxic damage, redox imbalances and other forms of cellular stress. Chemoprevention by edible phytochemicals is now considered to be an inexpensive, readily applicable, acceptable and accessible approach to cancer control and management. The present short review deals with a number of recent biochemical and therapeutic routes, concerning current approaches towards natural anticancer agents in clinical practice, new candidate oncotherapy drugs from plants, marine and microorganisms, as well as promising chemopreventing agents from nature.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21229622

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  33 in total

1.  Anticancer potential of selected Fallopia Adans species.

Authors:  Octavian Tudorel Olaru; Luanne Venables; Maryna VAN DE Venter; George Mihai Nitulescu; Denisa Margina; Demetrios A Spandidos; Aristidis M Tsatsakis
Journal:  Oncol Lett       Date:  2015-07-02       Impact factor: 2.967

2.  Guggulsterone inhibits human cholangiocarcinoma Sk-ChA-1 and Mz-ChA-1 cell growth by inducing caspase-dependent apoptosis and downregulation of survivin and Bcl-2 expression.

Authors:  Fei Zhong; Jing Yang; Zhu-Ting Tong; Liu-Liu Chen; Lu-Lu Fan; Fang Wang; Xia-Li Zha; Jun Li
Journal:  Oncol Lett       Date:  2015-06-19       Impact factor: 2.967

3.  Phenylboronic acid is a more potent inhibitor than boric acid of key signaling networks involved in cancer cell migration.

Authors:  Erin M McAuley; Tiffany A Bradke; George E Plopper
Journal:  Cell Adh Migr       Date:  2011 Sep-Oct       Impact factor: 3.405

4.  A Newly Synthesized Derivative and a Natural Parent Molecule: Which Would Be More Beneficial as a Future Antitumor Candidate? Docking and In Vivo Study.

Authors:  Entsar A Saad; Faten Zahran; Fawzia Z El-Ablack; Ahmed M Abo Eleneen
Journal:  Appl Biochem Biotechnol       Date:  2022-07-02       Impact factor: 3.094

Review 5.  Plants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability.

Authors:  Hu Wang; Tin Oo Khor; Limin Shu; Zheng-Yuan Su; Francisco Fuentes; Jong-Hun Lee; Ah-Ng Tony Kong
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

Review 6.  The reversal of antineoplastic drug resistance in cancer cells by β-elemene.

Authors:  Guan-Nan Zhang; Charles R Ashby; Yun-Kai Zhang; Zhe-Sheng Chen; Huiqin Guo
Journal:  Chin J Cancer       Date:  2015-09-14

7.  The apoptotic effect of D Rhamnose β-hederin, a novel oleanane-type triterpenoid saponin on breast cancer cells.

Authors:  Lin Cheng; Tian-Song Xia; Yi-Fen Wang; Wenbin Zhou; Xiu-Qing Liang; Jin-Qiu Xue; Liang Shi; Ying Wang; Qiang Ding
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

8.  A phase I study of the safety and activity of K-001 in patients with advanced pancreatic ductal adenocarcinoma.

Authors:  Jiujie Cui; Haiyan Yang; Jue Liu; Donghui Chen; Jiong Hu; Haiyan Zhang; Yu Wang; Ting Han; Tiebo Mao; Feng Jiao; Ewelina Biskup; Yaotian Pan; Min Liu; Liwei Wang
Journal:  BMC Cancer       Date:  2021-06-07       Impact factor: 4.430

9.  Scoparone exerts anti-tumor activity against DU145 prostate cancer cells via inhibition of STAT3 activity.

Authors:  Jeong-Kook Kim; Joon-Young Kim; Han-Jong Kim; Keun-Gyu Park; Robert A Harris; Won-Jea Cho; Jae-Tae Lee; In-Kyu Lee
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

10.  Gracilaria edulis extract induces apoptosis and inhibits tumor in Ehrlich ascites tumor cells in vivo.

Authors:  Satyajit Patra; Meenakshi Sundaram Muthuraman
Journal:  BMC Complement Altern Med       Date:  2013-11-25       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.